IGFBP2 and hemolytic-uremic syndrome: As shown in Figure 3, the serum IGFBP2 levels in patients with encephalopathy showed a significant and sharp increase with the progression of HUS (p<.05) whereas there was no increase in serum IGFBP2 levels with the progression of disease in patients with mild HUS.